首页> 外文期刊>Obstetrical and gynecological survey >Han Chinese Polycystic Ovary Syndrome Risk Variants in Women of European Ancestry: Relationship to FSH Levels and Glucose Tolerance EDITORIAL COMMENT
【24h】

Han Chinese Polycystic Ovary Syndrome Risk Variants in Women of European Ancestry: Relationship to FSH Levels and Glucose Tolerance EDITORIAL COMMENT

机译:欧洲祖先妇女汉族多囊卵巢综合征风险变异:与FSH水平和糖耐量的关系编辑评论

获取原文
获取原文并翻译 | 示例
           

摘要

Polycystic ovary syndrome (PCOS) affects 7% to 10% of reproductive-age women. The etiology of the syndrome is poorly understood. Twin studies suggest that the pathogenesis of PCOS in more than 70% of cases can be explained by genetic influences. Risk loci for genetic variants associated with the syndrome have been identified in women of Han Chinese ethnicity. Two genome-wide association studies in Han Chinese women identified risk loci for 11 genetic variants. Three of these 11 variants were also associated with PCOS in at least 1 European population when corrected for multiple testing, including DENND1A, THADA, and YAP1. The PCOS variants identified require additional replication in Greek and US women to establish the importance of these variants and to determine their relationship to PCOS phenotypic traits. This case-control study was designed to investigate whether PCOS risk variants identified in women of Han Chinese ethnicity were also associated with risk of PCOS or its phenotypic features in European and US women. The discovery cohort was composed of women with PCOS (n = 485) and control subjects (n = 407) from Boston (Boston 1). Susceptibility variants were examined in replicate populations in Greece (cases n = 884 and control subjects n = 311), and a second cohort from Boston identified through the electronic medical record (EMR), n = 350 cases and n = 1258 control subjects). Women in Boston 1 and Greece (n = 783) had PCOS defined by the National Institutes of Health criteria (irregular menses and clinical or biochemical hyperandrogenism [n = 527]), with additional subjects fulfilling the Rotterdam criteria (clinical or biochemical hyperandrogenism, polycystic ovary morphology, and regular menstrual cycles [n = 101]). Control subjects in Boston and Greece had regular menses and no hyperandrogenism. The second Boston cohort was defined using the EMR and natural language processing. Allele frequencies for PCOS risk variants identified in Han Chinese women were examined in PCOS cases and control subjects, along with the relationship to quantitative traits. One variant, rs2268361-T, in the intron of follicle-stimulating hormone receptor (FSHR) was associated with PCOS; the combined odds ratio was 0.84 (95% confidence interval, 0.76-0.93; P = 0.002). This variant was associated with lower follicle-stimulating hormone (FSH) levels (-0.15 0.05; P = 0.0029). Another variant, rs705702-G, near the RAB5B and SUOX genes, was associated with lower insulin (-0.16 0.05; P = 0.0029) and glucose levels (-0.20 0.05; P = 0.0002) 120 minutes after an oral glucose test, suggesting better insulin sensitivity. Although the study was large and contained replication cohorts, the findings were limited by a small number of control subjects in the Greek cohort and a small number of cases in the second Boston cohort. Moreover, it was possible that the second Boston cohort identified with EMR review could contribute to the observed differences; this cohort, however, was validated for the cardinal features of PCOS. These findings show that a PCOS risk variant present in Han Chinese women in the region of FSHR is also associated with PCOS in women of European ethnicity. This cross-ethnic PCOS risk locus, rs2268361-T, may influence FSH receptor responsiveness as suggested by the associated change in FSH levels and suggest that disrupting FSH stimulation of follicle development is a key etiologic feature of PCOS.
机译:多囊卵巢综合征(PCOS)影响7%至10%的育龄妇女。该综合征的病因知之甚少。两项研究表明,在超过70%的病例中,PCOS的发病机理可以通过遗传影响来解释。已经在汉族妇女中确定了与该综合征相关的遗传变异的风险基因座。在汉族女性中进行的两项全基因组关联研究确定了11个遗传变异的风险基因座。经过多重测试校正后,这11个变体中的三个也与至少1个欧洲人口的PCOS相关,包括DENND1A,THADA和YAP1。确定的PCOS变体需要在希腊和美国女性中进行额外复制,以确立这些变体的重要性并确定其与PCOS表型性状的关系。这项病例对照研究旨在调查在汉族女性中发现的PCOS风险变异是否也与欧美女性中PCOS风险或其表型特征相关。该发现队列由来自波士顿(波士顿1)的PCOS女性(n = 485)和对照组(n = 407)组成。在希腊的重复人群中检查了药敏性变异(病例n = 884,对照对象n = 311),并通过电子病历(EMR)确定了波士顿的第二个队列,n = 350例,n = 1258对照对象。波士顿1区和希腊的女性(n = 783)具有美国国立卫生研究院标准(月经不调以及临床或生化高雄激素血症[n = 527])定义的PCOS,其他受试者符合鹿特丹标准(临床或生化高雄激素血症,多囊性)卵巢形态和规律的月经周期[n = 101])。波士顿和希腊的对照受试者月经规律,无雄激素过多症。使用EMR和自然语言处理定义了第二个波士顿队列。在PCOS病例和对照受试者中检查了汉族女性中PCOS风险变异的等位基因频率,以及与数量性状的关系。促卵泡激素受体(FSHR)内含子中的一个变体rs2268361-T与PCOS相关。组合优势比为0.84(95%置信区间0.76-0.93; P = 0.002)。该变异与较低的卵泡刺激素(FSH)水平相关(-0.15 0.05; P = 0.0029)。口服葡萄糖测试后120分钟,靠近RAB5B和SUOX基因的另一种变体rs705702-G与较低的胰岛素(-0.16 0.05; P = 0.0029)和血糖水平(-0.20 0.05; P = 0.0002)相关,提示更好胰岛素敏感性。尽管该研究规模较大且包含复制队列,但研究结果受到希腊队列中少数对照对象和波士顿第二队列中少数病例的限制。此外,通过EMR审查确定的第二个波士顿队列有可能有助于观察到的差异;然而,该队列已针对PCOS的基本特征进行了验证。这些发现表明,FSHR地区汉族女性中存在PCOS风险变异也与欧洲族裔女性的PCOS相关。正如FSH水平的相关变化所暗示的那样,这种跨种族的PCOS危险基因位点rs2268361-T可能会影响FSH受体反应,并提示破坏FSH刺激卵泡发育是PCOS的关键病因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号